Ratings
0
Nobody has rated this yet. Be the first!
Works
6
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
.png/500px-American_Academy_of_Arts_and_Sciences_(ancient_logo).png)